Oxcarbazepine treatment of restless legs syndrome: Three case reports

Clinical Neuropharmacology

Volumn 32, Issue 3, 2009, Pages 169-170

  Jimenez Trevino, Luis ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Movement disorders; Oxcarbazepine; Restless legs syndrome; Sleep disorders

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; OXCARBAZEPINE; TOPIRAMATE;

ADULT; AGED; AROUSAL; ARTICLE; BEDTIME DOSAGE; CASE REPORT; DIZZINESS; DRUG DOSE INCREASE; FEMALE; HUMAN; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; REMISSION; RESTLESS LEGS SYNDROME; SEDATION; SEROLOGY; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; ANTICONVULSANTS; CARBAMAZEPINE; FEMALE; HUMANS; MIDDLE AGED; RESTLESS LEGS SYNDROME;

EID: 67651171379     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31818f1125     Document Type: Article

References (6)

1. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165(11):1286-1292 (Pubitemid 40989594)
2. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med Mar 2003;4(2):101-119
3. Telstad W, Sorensen O, Larsen S, et al. Treatment of the restless legs syndrome with carbamazepine: a double blind study. Br Med J 1984;288:444-446 (Pubitemid 14121123)
4. Zucconi M, Coccagna G, Petronelli R, et al. Nocturnal myoclonus in restless legs syndrome effect of carbamazepine treatment. Funct Neurol 1989;4(3):263-271 (Pubitemid 19216422)
5. Lundvall O, Abom PE, Holm R. Carbamazepine in restless legs. A controlled pilot study. Eur J Clin Pharmacol 1983;25(3):323-324
6. Oztürk O, Eraslan D, Kumrral E, . Oxcarbazepine treatment for paroxetine-induced restless leg syndrome. Gen Hosp Psychiatry 2006;28(3):264-265